Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$223.05 - $302.68 $10.2 Million - $13.9 Million
-45,800 Reduced 11.88%
339,700 $97 Million
Q1 2023

May 12, 2023

BUY
$175.41 - $217.92 $9.84 Million - $12.2 Million
56,100 Added 17.03%
385,500 $83.6 Million
Q4 2022

Feb 14, 2023

SELL
$204.38 - $296.82 $40.1 Million - $58.2 Million
-196,100 Reduced 37.32%
329,400 $67.7 Million
Q3 2022

Nov 14, 2022

BUY
$195.21 - $310.53 $22.8 Million - $36.2 Million
116,700 Added 28.55%
525,500 $146 Million
Q2 2022

Aug 15, 2022

BUY
$115.91 - $214.48 $47.4 Million - $87.7 Million
408,800 New
408,800 $78.2 Million
Q4 2021

Feb 15, 2022

SELL
$165.13 - $241.83 $4.13 Million - $6.05 Million
-25,000 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$163.99 - $235.57 $4.1 Million - $5.89 Million
25,000 New
25,000 $5.17 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track 1832 Asset Management L.P. Portfolio

Follow 1832 Asset Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on 1832 Asset Management L.P. with notifications on news.